Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Veterans Affairs was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Benazepril Hydrochloride (HCL) Tablets

Closed
36E79726R0026Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 21 days

AI Contract Overview

Show more

This solicitation issued by the Department of Veterans Affairs (VA) seeks proposals for the procurement of Benazepril Hydrochloride (HCL) tablets in multiple dosage strengths, along with related cardiovascular medications like Captopril and Carvedilol. The requirement encompasses baseline quantities for a one-year base period with four one-year options, offering a five-year potential contract term. While prices are not specified in the solicitation, firm fixed quantities per dosage strength are defined, with delivery directed to government prime vendor distribution centers. The manufacturing sources must be FDA-approved, comply with current Good Manufacturing Practices, and hold appropriate New Drug Application or Abbreviated New Drug Application authorizations. The contract award will be based on a Lowest Price Technically Acceptable (LPTA) evaluation model, requiring all offerors to meet rigorous pass/fail technical criteria including correct product specifications, unique National Drug Codes (NDCs), and certification that the products meet FDA and USP-NF standards. Packaging and labeling requirements are stringent to ensure pharmacological integrity, safety, and traceability. Child-resistant closures are mandatory for bottles with 400 tablets or fewer, excluding glass containers. All packaging must pass stability testing and be compatible with automated dispensing systems utilized by the VA. Bar coding is required on unit-of-use packages to conform with industry standards such as GS1-128 or HIBC, encoding the NDC number with a human-readable counterpart for barcode medication administration systems. Labels must not be over-labeled except by the VA with secure adhesion. The contract incorporates typical federal contract clauses, including those restricting prohibited telecommunications equipment, requirements for small business subcontracting plans with dedicated goals for veteran and disability-owned businesses, organizational conflict of interest stipulations, and compliance with federal ethics and procurement standards. Proposals must be submitted electronically by the specified deadline, include representations, certifications, pricing for all line items and option years, and adhere to the solicitation’s formatting instructions. Final performance periods, payment sites, and contract administration details will be specified upon contract award.

General Info

VA seeks FDA-approved cardiovascular drug suppliers for five-year, fixed-quantity, LPTA contract.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(2)

RFP 36E79726R0026 Benazepril Hydrochloride Tablets

DOCXpresolicitation

36E79726R0026.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Office AddressHINES, IL, 60141, USA
Contacts
Andrew J CazaresContract Specialist

Full Description

Show more
N/A